Statement Of Financial Position [Abstract]

Sopharma AD - Filing #6022429

Concept As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
Statement of financial position [abstract]
Assets [abstract]
Property, plant and equipment
376 407 BGN
362 393 BGN
Investment property
10 568 BGN
9 446 BGN
Goodwill
3 522 BGN
13 420 BGN
Intangible assets other than goodwill
48 151 BGN
54 421 BGN
Deferred tax assets
2 052 BGN
1 050 BGN
Cash and cash equivalents
19 855 BGN
37 722 BGN
Assets
1 253 978 BGN
1 204 978 BGN
Equity and liabilities [abstract]
Equity [abstract]
Issued capital
134 798 BGN
134 798 BGN
Retained earnings
509 869 BGN
444 634 BGN
Other equity interest
12 488 BGN
12 512 BGN
Equity attributable to owners of parent
704 658 BGN
646 975 BGN
Non-controlling interests
11 976 BGN
11 893 BGN
Equity
68 628 BGN
716 634 BGN
35 263 BGN
12 488 BGN
11 976 BGN
509 869 BGN
52 203 BGN
134 798 BGN
4 745 BGN
704 658 BGN
560,000 BGN
50 284 BGN
66 201 BGN
36 788 BGN
444 634 BGN
658 868 BGN
1 644 BGN
12 512 BGN
646 975 BGN
11 893 BGN
682,000 BGN
134 798 BGN
63 335 BGN
28 425 BGN
360 770 BGN
13 326 BGN
553 269 BGN
134 798 BGN
33 656 BGN
2 685 BGN
566 595 BGN
2 282 BGN
Liabilities [abstract]
Deferred tax liabilities
6 397 BGN
8 472 BGN
Liabilities
537 344 BGN
546 110 BGN
Equity and liabilities
1 253 978 BGN
1 204 978 BGN

Talk to a Data Expert

Have a question? We'll get back to you promptly.